IL6 and neoplasm: Inflammatory markers like high-sensitivity C reactive protein (hs-CRP), interleukin-10 (IL-10), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-α) reflect the chronic inflammation associated with tumor initiation and progression [7].